Company registration number 15935010 (England and Wales)
JMB CLINICAL TRIALS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED
30 SEPTEMBER 2025
30 September 2025
PAGES FOR FILING WITH REGISTRAR
JMB CLINICAL TRIALS LIMITED
COMPANY INFORMATION
Director
Mrs J M Bakobaki
Company number
15935010
Registered office
C/o PM+M
New Century House
Challenge Way
Greenbank Technology Park
Blackburn
Lancashire
BB1 5QB
Accountants
PM+M Solutions for Business LLP
New Century House
Greenbank Technology Park
Challenge Way
Blackburn
Lancashire
BB1 5QB
JMB CLINICAL TRIALS LIMITED
CONTENTS
Page
Balance sheet and notes to the financial statements
1 - 2
JMB CLINICAL TRIALS LIMITED
BALANCE SHEET
AS AT
30 SEPTEMBER 2025
30 September 2025
- 1 -
2025
£
£
Fixed assets
1,545
Current assets
88,571
Creditors: amounts falling due within one year
(62,733)
Net current assets
25,838
Total assets less current liabilities
27,383
Net assets
27,383
Capital and reserves
27,383
Notes to the financial statements
1
Employees
The average number of persons, including directors, employed by the company during the period was as follows:
2025
Number
Employees
1
JMB Clinical Trials Limited is a private company limited by shares incorporated in England and Wales. The registered office is C/o PM+M, New Century House, Challenge Way, Greenbank Technology Park, Blackburn, Lancashire, BB1 5QB.
For the period ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.
These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime', and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true
JMB CLINICAL TRIALS LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 SEPTEMBER 2025
30 September 2025
- 2 -
The financial statements were approved and signed by the director and authorised for issue on 28 November 2025
Mrs J M Bakobaki
Director
Company registration number 15935010 (England and Wales)